ALNA
Goldman Sachs’s Allena Pharmaceuticals, Inc. Common Stock ALNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-23,339
| Closed | -$30K | – | 5430 |
|
|
2020
Q4 | $30K | Sell |
23,339
-55,595
| -70% | -$71.5K | ﹤0.01% | 4598 |
|
|
2020
Q3 | $117K | Buy |
78,934
+50,822
| +181% | +$75.3K | ﹤0.01% | 4195 |
|
|
2020
Q2 | $44K | Buy |
+28,112
| New | +$44K | ﹤0.01% | 4257 |
|
|
2020
Q1 | – | Sell |
-33,784
| Closed | -$92K | – | 4602 |
|
|
2019
Q4 | $92K | Sell |
33,784
-49,232
| -59% | -$134K | ﹤0.01% | 4140 |
|
|
2019
Q3 | $327K | Buy |
83,016
+13,708
| +20% | +$54K | ﹤0.01% | 3754 |
|
|
2019
Q2 | $282K | Buy |
69,308
+58,171
| +522% | +$237K | ﹤0.01% | 3744 |
|
|
2019
Q1 | $78K | Buy |
+11,137
| New | +$78K | ﹤0.01% | 4043 |
|
|
2018
Q4 | – | Sell |
-22,177
| Closed | -$238K | – | 4311 |
|
|
2018
Q3 | $238K | Sell |
22,177
-727
| -3% | -$7.8K | ﹤0.01% | 3751 |
|
|
2018
Q2 | $298K | Sell |
22,904
-6,303
| -22% | -$82K | ﹤0.01% | 3731 |
|
|
2018
Q1 | $322K | Sell |
29,207
-20,436
| -41% | -$225K | ﹤0.01% | 3676 |
|
|
2017
Q4 | $499K | Buy |
+49,643
| New | +$499K | ﹤0.01% | 3460 |
|